WindMIL Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- WindMIL Therapeutics's estimated annual revenue is currently $2M per year.
- WindMIL Therapeutics's estimated revenue per employee is $155,000
Employee Data
- WindMIL Therapeutics has 13 Employees.
- WindMIL Therapeutics grew their employee count by -19% last year.
WindMIL Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | EVP,CSO,Founder | Reveal Email/Phone |
2 | Senior Manager and Scientist I | Reveal Email/Phone |
3 | Senior Manager and Scientist I | Reveal Email/Phone |
4 | Laboratory Technician | Reveal Email/Phone |
5 | EVP,CSO,Founder | Reveal Email/Phone |
6 | Laboratory Technician | Reveal Email/Phone |
WindMIL Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.3M | 2 | -60% | N/A | N/A |
#2 | $2.9M | 38 | -31% | $17.5M | N/A |
#3 | $2.9M | 38 | -33% | $10.5M | N/A |
#4 | $19.8M | 128 | 0% | $69.4M | N/A |
#5 | $9.6M | 62 | -15% | N/A | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $7.4M | 48 | 0% | N/A | N/A |
#9 | $0.2M | 1 | -83% | N/A | N/A |
#10 | $1.7M | 11 | 22% | N/A | N/A |
What Is WindMIL Therapeutics?
WindMIL Therapeutics is a clinical stage oncology cell therapy company. We are leveraging our proprietary platform to develop a novel class of cell therapies called MILsâ„¢ (Marrow Infiltrating Lymphocytes) derived from memory T cells found in the bone marrow.
keywords:N/AN/A
Total Funding
13
Number of Employees
$2M
Revenue (est)
-19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
WindMIL Therapeutics News
Betalin Therapeutics, BioCardia Inc, BioReliance Corporation, Biosolution Co., ... Waisman Biomanufacturing, WindMIL Therapeutics Inc., Wuxi App Tec Inc.,...
Betalin Therapeutics, BioCardia Inc, BioReliance Corporation, Biosolution Co., ... Waisman Biomanufacturing, WindMIL Therapeutics Inc., Wuxi App Tec Inc.,...
... gamma-delta T cell therapies utilizing its DeltEx platform, ... as the VP of Regulatory and Quality Systems at WindMIL Therapeutics.
... gamma-delta T cell therapies utilizing its DeltEx platform, ... as the VP of Regulatory and Quality Systems at WindMIL Therapeutics.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.4M | 13 | -71% | N/A |
#2 | $1.4M | 13 | -19% | N/A |
#3 | $1.2M | 13 | -7% | N/A |
#4 | $2M | 13 | 44% | N/A |
#5 | $2M | 13 | -19% | N/A |